Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Asamer, E; Szkandera, J; Gibiser, P; Lembeck, AL; Stojakovic, T; Kornprat, P; Lackner, C; Winder, T; Schlick, K; Stöger, H; Gerger, A; Pichler, M; Stotz, M.
Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysis.
Wien Klin Wochenschr. 2018; 130(19-20):569-574 Doi: 10.1007/s00508-018-1383-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Führende Autor*innen der Med Uni Graz
Stotz Michael
Co-Autor*innen der Med Uni Graz
Gerger Armin
Kornprat Peter
Lackner Karoline
Pichler Martin
Schlick Konstantin
Stöger Herbert
Stojakovic Tatjana
Szkandera Joanna

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

BACKGROUND AND AIM: The aim of this study was to investigate the prognostic relevance of plasma amylase and lipase concerning survival of patients suffering from metastatic pancreatic cancer (PC). METHOD: This retrospective study included 351 patients with metastatic PC, who were treated in a single academic institution. Cancer-specific survival (CSS) was analyzed using the Kaplan-Meier method. To further evaluate the prognostic significance of lipase and amylase, univariate and multivariate values were calculated using Cox proportional models. RESULTS: In univariate analysis, an increased amylase level was associated with shorter CSS in PC patients (hazard ratio HR = 1.258; 95% confidence interval CI = 1.011-1.566; p = 0.039). In multivariate analysis, including gender, age, CA19-9 and administration of chemotherapy, increased amylase levels prevailed as an independent prognostic factor for CSS (HR = 1.373; 95%CI = 1.004-1.878; p = 0.047). CONCLUSIONS: Plasma amylase was found to be an independent prognostic factor in patients with metastatic PC. The results indicate that amylase might represent a novel and useful marker for better patient stratification in PC management.
Find related publications in this database (using NLM MeSH Indexing)
Adenocarcinoma - blood, enzymology
Aged - administration & dosage
Amylases - blood
Biomarkers, Tumor - blood
Female - administration & dosage
Humans - administration & dosage
Kaplan-Meier Estimate - administration & dosage
Male - administration & dosage
Middle Aged - administration & dosage
Pancreatic Neoplasms - blood, enzymology
Prognosis - administration & dosage
Proportional Hazards Models - administration & dosage
Retrospective Studies - administration & dosage

Find related publications in this database (Keywords)
© Med Uni Graz Impressum